Compendium of Cancer Genome Aberrations

CNS5:Volunteer Assignments and Opportunities: Difference between revisions

← Older edit
VisualWikitext
No edit summary
m due date
 
(49 intermediate revisions by 5 users not shown)
Line 5: Line 5:
If empty (no name is present), please volunteer to create content for that disease!
If empty (no name is present), please volunteer to create content for that disease!


To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br />
 
__TOC__
==WHO Classification of Tumours of the Central Nervous System (5th Edition) Content==
{| class="wikitable" style="margin:auto"
{| class="wikitable"
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>
|-
|-
!'''Disease'''!!'''Page Type'''!!!!<span style="color:#0070C0">'''Author'''
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Target Completion Date'''
Line 18: Line 18:
!'''Notes'''
!'''Notes'''
|-
|-
|Astrocystoma, IDH-Mutant
|
====CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[CNS5:Astrocytoma,_IDH-mutant|Astrocytoma, IDH-mutant]]
|Disease
|Disease
|Meenakshi Mehrotra
|Meenakshi Mehrotra
|6/25/2023
|6/25/2023
|
|
|PENDING
|COMPLETE
|
|
|Laveniya Satgunaseelan (LS)
|Laveniya Satgunaseelan (LS)
Line 29: Line 50:
|2021 template added
|2021 template added
|-
|-
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease||Riley Lochner (trainee), Shashi Shetty (mentor)
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
|Disease
|Riley Lochner (trainee);
Shashi Shetty (mentor)
|6/7/2022
|6/7/2022
|
|
Line 38: Line 62:
|2021 template added
|2021 template added
|-
|-
|Glioblastoma, IDH-Wildtype||Disease||Meenakshi Mehrotra
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
|
|Disease
|
|Jieying Wu
|11/18/2025
|01/15/2026
|PENDING
|PENDING
|
|
|LS
|LS
|
|
|Moved from "Glioblasoma, IDH-wildtype" to new page; 2021 template added
|Moved from "Glioblastoma, IDH-wildtype" to new page; 2021 template added
|-
|-
|Diffuse Astrocytoma, MYB- or MYBL1-Altered||Disease||Scott Smith
|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
|Disease
|Scott Smith
|6/27/2023
|6/27/2023
|
|
|PENDING
|COMPLETE
|
|
|LS
|LS
Line 56: Line 84:
|2021 template added (page created 6/27/23)
|2021 template added (page created 6/27/23)
|-
|-
|Angiocentric Glioma||Disease||
|[[CNS5:Angiocentric_glioma|Angiocentric glioma]]
|Disease
|
|
|
|
|
Line 65: Line 95:
|
|
|-
|-
|Polymorphous Low-Grade Neuroepithelial Tumour of the Young||Disease||
|[[CNS5:Polymorphous_low-grade_neuroepithelial_tumour_of_the_young|Polymorphous low-grade neuroepithelial tumour of the young]]
|Disease
|
|
|
|
|
Line 74: Line 106:
|
|
|-
|-
|Diffuse Low-Grade Glioma, MAPK Pathway-Altered||Disease||
|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered]]
|
|Disease
|
|Scott Smith
|
|5/3/2024
|
|
|PENDING - email reminder 9/4/2025
|
|
|LS
|
|
|
|
|-
|-
|Diffuse Midline Glioma, H3 K27-Altered||Disease||Laveniya Satgunaseelan (Linda Cooley - previous version)
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
|Disease
|Laveniya Satgunaseelan
|
|
|
|
|PENDING
|COMPLETE
|
|
|LS
|LS
Line 92: Line 128:
|2021 template added
|2021 template added
|-
|-
|Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease||Xiaolin (Lynn) Hu
|[[CNS5:Diffuse_hemispheric_glioma,_H3_G34-mutant|Diffuse hemispheric glioma, H3 G34-mutant]]
|Disease
|Xiaolin (Lynn) Hu
|2/21/2022
|2/21/2022
|
|
Line 101: Line 139:
|2021 template added
|2021 template added
|-
|-
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease||Madina Sukhanova
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
|Disease
|Madina Sukhanova
|10/28/2022
|10/28/2022
|
|
Line 110: Line 161:
|2021 template added
|2021 template added
|-
|-
|Infant-Type Hemispheric Glioma||Disease||
|[[CNS5:Infant-type_hemispheric_glioma|Infant-type hemispheric glioma]]
|Disease
|
|
|
|
|
|
Line 117: Line 171:
|
|
|
|
|2021 template added
|-
|-
|Pilocytic Astrocytoma||Disease||Jeremy Pulvers
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]]
|9/13/2022<br />
|Disease
|Layla Zhu
|<br />3/2/2026
|
|
|PENDING
|PENDING
Line 128: Line 183:
|2021 template added
|2021 template added
|-
|-
|High-Grade Astrocytoma with Piloid Features||Disease||
|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
|
|Disease
|
|Wahab Khan
|2/8/2026
|
|
|PENDING
|
|
|
|
Line 137: Line 194:
|
|
|-
|-
|Pleomorphic Xanthoastrocytoma||Disease||
|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
|
|Disease
|
|Wahab Khan
|
|15/04/2025
|
|
|COMPLETE
|2/8/2026 (Feb 8)
|LS
|LS
|
|
|2021 template added
|2021 template added
|-
|-
|Subependymal Giant Cell Astrocytoma||Disease||
|[[CNS5:Subependymal_giant_cell_astrocytoma|Subependymal giant cell astrocytoma]]
|Disease
|
|
|
|
|
Line 155: Line 216:
|
|
|-
|-
|Chordoid Glioma||Disease||
|[[CNS5:Chordoid_glioma|Chordoid glioma]]
|Disease
|
|
|
|
|
Line 164: Line 227:
|
|
|-
|-
|Astroblastoma, MN1-Altered||Disease||
|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
|
|Disease
|
|Milana.Djonovic (trainee), Laveniya/Madina
|
|4/26/2026
|
|6/15/2026
|PENDING
|
|
|LS
|
|
|
|
|-
|-
|Ganglioglioma||Disease||Leila Moayed-Aloei
|[[CNS5:Ganglioglioma|Ganglioglioma]]
|Disease
|Leila Moayed-Aloei
|6/30/2022
|6/30/2022
|
|
Line 182: Line 249:
|2021 template added
|2021 template added
|-
|-
|Gangliocytoma||Disease||
|[[CNS5:Gangliocytoma|Gangliocytoma]]
|Disease
|
|
|
|
Line 190: Line 258:
|
|
|
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|Desmoplastic Infantile Ganglioglioma/Desmoplastic Infantile Astrocytoma||Disease||
|[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
|Disease
|
|
|
|
|
Line 200: Line 282:
|
|
|-
|-
|Dysembryoplastic Neuroepithelial Tumour||Disease||
|[[CNS5:Dysembryoplastic_neuroepithelial_tumour|Dysembryoplastic neuroepithelial tumour]]
|Disease
|
|
|
|
|
Line 209: Line 293:
|
|
|-
|-
|Diffuse Glioneuronal Tumour with Oligodendroglioma-Like Features and Nuclear Clusters||Disease||
|[[CNS5:Diffuse_glioneuronal_tumour_with_oligodendroglioma-like_features_and_nuclear_clusters|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters]]
|Disease
|
|
|
|
|
Line 218: Line 304:
|
|
|-
|-
|Papillary Glioneuronal Tumour||Disease||
|[[CNS5:Papillary_glioneuronal_tumour|Papillary glioneuronal tumour]]
|Disease
|
|
|
|
|
Line 227: Line 315:
|
|
|-
|-
|Rosette-Forming Glioneuronal Tumour||Disease||
|[[CNS5:Rosette-forming_glioneuronal_tumour|Rosette-forming glioneuronal tumour]]
|Disease
|
|
|
|
|
Line 236: Line 326:
|
|
|-
|-
|Myxoid Glioneuronal Tumour||Disease||
|[[CNS5:Myxoid_glioneuronal_tumour|Myxoid glioneuronal tumour]]
|Disease
|
|
|
|
|
Line 245: Line 337:
|
|
|-
|-
|Diffuse Lptomeningeal Glioneuronal Tumour||Disease||
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
|Disease
|Laveniya Satgunaseelan
|9/11/2024
|
|COMPLETE
|8/7/2025
|LS
|LS
|Used for testing 9/2024 somatic template
|-
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
|Disease
|
|
|
|
|
Line 254: Line 359:
|
|
|-
|-
|Multinodular and Vacuolating Neuronal Tumour||Disease||
|[[CNS5:Dysplastic_cerebellar_gangliocytoma_(Lhermitte-Duclos_disease)|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)]]
|Disease
|
|
|
|
|
Line 263: Line 370:
|
|
|-
|-
|Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease)||Disease||
|[[CNS5:Central_neurocytoma|Central neurocytoma]]
|Disease
|
|
|
|
|
Line 272: Line 381:
|
|
|-
|-
|Central Neurocytoma||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]]
|Disease
|
|
|
|
|
Line 281: Line 403:
|
|
|-
|-
|Extraventricular Neurocytoma||Disease||
|[[CNS5:Cerebellar_liponeurocytoma|Cerebellar liponeurocytoma]]
|Disease
|
|
|
|
|
Line 290: Line 414:
|
|
|-
|-
|Cerebellar Liponeurocytoma||Disease||
|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
|Disease
|Laveniya Satgunaseelan
|2/4/2026
|30/6/2026
|PENDING
|
|
|
|
|
|
|
|-
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive]]
|Disease
|Laveniya Satgunaseelan
|2/4/2026
|30/6/2026
|PENDING
|
|
|
|
Line 299: Line 436:
|
|
|-
|-
|Supratentorial Ependymoma||Disease||
|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
|Disease
|Laveniya Satgunaseelan
|2/4/2026
|30/6/2026
|PENDING
|
|
|
|
|
|
|
|
|-
|[[CNS5:Posterior_fossa_ependymoma|Posterior fossa ependymoma]]
|Disease
|
|
|
|
|
|-
|Supratentorial Ependymoma, ZFTA Fusion-Positive||Disease||
|
|
|
|
Line 315: Line 457:
|
|
|
|
|-
|[[CNS5:Posterior_fossa_group_A_(PFA)_ependymoma|Posterior fossa group A (PFA) ependymoma]]
|Disease
|
|
|-
|Supratentorial Ependymoma, YAP1 Fusion-Positive||Disease||
|
|
|
|
Line 326: Line 469:
|
|
|-
|-
|Posterior Fossa Ependymoma||Disease||
|[[CNS5:Posterior_fossa_group_B_(PFB)_ependymoma|Posterior fossa group B (PFB) ependymoma]]
|Disease
|
|
|
|
|
Line 335: Line 480:
|
|
|-
|-
|Posterior Fossa Group A (PFA) Ependymoma||Disease||
|[[CNS5:Spinal_ependymoma|Spinal ependymoma]]
|Disease
|
|
|
|
|
Line 344: Line 491:
|
|
|-
|-
|Posterior Fossa Group B (PFB) Ependymoma||Disease||
|[[CNS5:Spinal_ependymoma,_MYCN-amplified|Spinal ependymoma, MYCN-amplified]]
|Disease
|
|
|
|
|
Line 353: Line 502:
|
|
|-
|-
|Spinal Ependymoma||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
|Disease
|
|
|
|
|
Line 362: Line 524:
|
|
|-
|-
|Spinal Ependymoma, MYCN-Amplified||Disease||
|[[CNS5:Subependymoma|Subependymoma]]
|Disease
|
|
|
|
|
Line 371: Line 535:
|
|
|-
|-
|Myxopapillary Ependymoma||Disease||
|
|
====CHAPTER 3 (CHOROID PLEXUS TUMOURS)====
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
----
|-
|-
|Subependymoma||Disease||
|[[CNS5:Choroid_plexus_papilloma|Choroid plexus papilloma]]
|Disease
|
|
|
|
|
Line 389: Line 567:
|
|
|-
|-
|Choroid Plexus Papilloma||Disease||
|[[CNS5:Atypical_choroid_plexus_papilloma|Atypical choroid plexus papilloma]]
|Disease
|
|
|
|
|
Line 398: Line 578:
|
|
|-
|-
|Atypical Choroid Plexus Papilloma||Disease||
|[[CNS5:Choroid_plexus_carcinoma|Choroid plexus carcinoma]]
|Disease
|
|
|
|
|
Line 407: Line 589:
|
|
|-
|-
|Choroid Plexus Carcinoma||Disease||
|
|
====CHAPTER 4 (EMBRYONAL TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
----
|
----
|-
|-
|Medulloblastoma, WNT-Activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
|Disease
|Lisa Lansdon, PhD (LGG trainee just finished);
Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|9/20/21
|9/20/21
|
|
Line 425: Line 622:
|2021 template added
|2021 template added
|-
|-
|Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease||
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-wildtype|Medulloblastoma, SHH-activated and TP53-wildtype]]
|Disease
|
|
|
|
|
Line 434: Line 633:
|
|
|-
|-
|Medulloblastoma, SHH-Activated and TP53-Mutant||Disease||
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
|Disease
|Hannah Wollenzien
|1/11/2026
|
|
|Pending
|
|
|MS
|
|
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
|Disease
|
|
|
|
|
|
|-
|Medulloblastoma, Non-WNT/Non-SHH||Disease||
|
|
|
|
Line 449: Line 665:
|
|
|
|
|-
|[[CNS5:Medulloblastoma,_histologically_defined|Medulloblastoma, histologically defined]]
|Disease
|
|
|
|
|-
|Medulloblastoma, Histologically Defined||Disease||
|
|
|
|
Line 459: Line 676:
|
|
|
|
|-
|[[CNS5:Atypical_teratoid/rhabdoid_tumour|Atypical teratoid/rhabdoid tumour]]
|Disease
|
|
|-
|Atypical Teratoid/Rhabdoid Tumour||Disease||
|
|
|
|
Line 470: Line 688:
|
|
|-
|-
|Cribriform Neuroepithelial Tumour||Disease||
|[[CNS5:Cribriform_neuroepithelial_tumour|Cribriform neuroepithelial tumour]]
|Disease
|
|
|
|
|
Line 479: Line 699:
|
|
|-
|-
|Embryonal Tumour with Multilayered Rosettes||Disease||
|[[CNS5:Embryonal_tumour_with_multilayered_rosettes|Embryonal tumour with multilayered rosettes]]
|Disease
|
|
|
|
|
Line 488: Line 710:
|
|
|-
|-
|CNS Neuroblastoma, FOXR2-Activated||Disease||
|[[CNS5:CNS_neuroblastoma,_FOXR2-activated|CNS neuroblastoma, FOXR2-activated]]
|Disease
|
|
|
|
|
Line 497: Line 721:
|
|
|-
|-
|CNS Tumour with BCOR Internal Tandem Duplication||Disease||
|[[CNS5:CNS_tumour_with_BCOR_internal_tandem_duplication|CNS tumour with BCOR internal tandem duplication]]
|Disease
|
|
|
|
|
Line 506: Line 732:
|
|
|-
|-
|CNS Embryonal Tumour NEC/NOS||Disease||
|[[CNS5:CNS_embryonal_tumour_NEC/NOS|CNS embryonal tumour NEC/NOS]]
|Disease
|
|
|
|
|
Line 515: Line 743:
|
|
|-
|-
|Pineocytoma||Disease||
|
|
====CHAPTER 5 (PINEAL TUMOURS)====
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Pineal Parenchymal Tumour of Intermediate Differentiation||Disease||
|
|
----
|
|
----
|-
|[[CNS5:Pineocytoma|Pineocytoma]]
|Disease
|
|
|
|
Line 532: Line 771:
|
|
|
|
|-
|Pineoblastoma||Disease||
|
|
|
|
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Pineal_parenchymal_tumour_of_intermediate_differentiation|Pineal parenchymal tumour of intermediate differentiation]]
|Disease
|
|
|
|
|
|
|
|
|-
|Papillary Tumour of the Pineal Region||Disease||
|
|
|
|
|
|
|
|
|-
|[[CNS5:Pineoblastoma|Pineoblastoma]]
|Disease
|Fang Fang (trainee)+Katie Schieffer (mentor)
|11/19/2025
|6/15/2026
|Pending
|
|
|LS
|
|
|
|
|-
|-
|Desmoplastic Myxoid Tumour of the Pineal Region, SMARCB1-Mutant||Disease||
|[[CNS5:Papillary_tumour_of_the_pineal_region|Papillary tumour of the pineal region]]
|Disease
|
|
|
|
|
Line 560: Line 819:
|
|
|-
|-
|Schwannoma||Disease||
|[[CNS5:Desmoplastic_myxoid_tumour_of_the_pineal_region,_SMARCB1-mutant|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant]]
|Disease
|
|
|
|
|
Line 569: Line 830:
|
|
|-
|-
|Neurofibroma||Disease||
|
|
====CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Perineurioma||Disease||
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Schwannoma|Schwannoma]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Neurofibroma|Neurofibroma]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Perineurioma|Perineurioma]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|Hybrid Nerve Sheath Tumours||Disease||
|[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
|Disease
|
|
|
|
Line 595: Line 935:
|
|
|
|
|-
|Malignant Melanotic Nerve Sheath Tumour||Disease||
|
|
|
|
|
|
|-
|
|
====CHAPTER 7 (MENINGIOMA)====
|
|
----
|
|
----
|
|
|-
----
|Malignant Peripheral Nerve Sheath Tumour||Disease||
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Meningioma|Meningioma]]
|Disease
|
|
|-
|Cauda Equina Neuroendocrine Tumour (Previously Paraganglioma)||Disease||
|
|
|
|
Line 623: Line 971:
|
|
|-
|-
|Meningioma||Disease||
|
|
====CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Solitary Fibrous Tumour||Disease||
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Haemangiomas_and_vascular_malformations|Haemangiomas and vascular malformations]]
|Disease
|
|
|
|
|
|
|-
|Haemangiomas and Vascular Malformations||Disease||
|
|
|
|
Line 647: Line 1,013:
|
|
|
|
|-
|[[CNS5:Haemangioblastoma|Haemangioblastoma]]
|Disease
|
|
|
|
|-
|Haemangioblastoma||Disease||
|
|
|
|
Line 657: Line 1,024:
|
|
|
|
|-
|[[CNS5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
|Disease
|
|
|-
|Rhabdomyosarcoma||Disease||
|
|
|
|
Line 668: Line 1,036:
|
|
|-
|-
|Intracranial Mesenchymal Tumour, FET::CREB Fusion-Positive||Disease||
|[[CNS5:Intracranial_mesenchymal_tumour,_FET::CREB_fusion-positive|Intracranial mesenchymal tumour, FET::CREB fusion-positive]]
|Disease
|
|
|
|
|
Line 677: Line 1,047:
|
|
|-
|-
|CIC-Rearranged Sarcoma||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Primary_intracranial_sarcoma,_DICER1-mutant|Primary intracranial sarcoma, DICER1-mutant]]
|Disease
|
|
|
|
Line 685: Line 1,077:
|
|
|
|
|-
|Primary Intracranial Sarcoma, DICER1-Mutant||Disease||
|
|
|
|
|-
|[[CNS5:Ewing_sarcoma|Ewing sarcoma]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Chondrosarcoma|Chondrosarcoma]]
|Disease
|
|
|
|
|
|-
|Ewing Sarcoma||Disease||
|
|
|
|
Line 702: Line 1,112:
|
|
|
|
|-
|[[CNS5:Chordoma|Chordoma]]
|Disease
|
|
|-
|Mesenchymal Chondrosarcoma||Disease||
|
|
|
|
Line 713: Line 1,124:
|
|
|-
|-
|Chondrosarcoma||Disease||
|
|
====CHAPTER 9 (MELANOCYTIC TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Chordoma||Disease||
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
|Disease
|
|
|
|
|
|
|-
|Diffuse Meningeal Melanocytic Neoplasms: Melanocytosis and Melanomatosis||Disease||
|
|
|
|
Line 738: Line 1,155:
|
|
|
|
|-
|[[CNS5:Circumscribed_meningeal_melanocytic_neoplasms:_Melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma]]
|Disease
|
|
|-
|Circumscribed Meningeal Melanocytic Neoplasms: Melanocytoma and Melanoma||Disease||
|
|
|
|
Line 749: Line 1,167:
|
|
|-
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|
|
====CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Immunodeficiency-Associated CNS Lymphomas||Disease||
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]]
|Disease
|
|
|
|
|
|
|
|
|-
|Lymphomatoid Granulomatosis||Disease||
|
|
|
|
|
|
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
|Disease
|
|
|
|
|
|
|-
|Intravascular Large B-cell Lymphoma||Disease||
|
|
|
|
Line 782: Line 1,220:
|
|
|
|
|-
|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|MALT Lymphoma of the Dura||Disease||
|[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]]
|
|Disease
|
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|
|N/A
|
|N/A
|
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]]
|Disease
|
|
|-
|Other Low-Grade B-cell Lymphomas of the CNS||Disease||
|
|
|
|
Line 803: Line 1,265:
|
|
|-
|-
|Anaplastic Large Cell Lymphoma (ALK+/ALK−)||Disease||Jennie Thurston
|[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]]
|Disease
|Jennie Thurston
|7/2/2023
|7/2/2023
|
|
Line 810: Line 1,274:
|MS
|MS
|
|
|2021 template added
|2021 template added; Did not yet convert to CNS5 namespace. Should Jennie instead do the related two pages in HAEM5 of "[[HAEM5:ALK-positive anaplastic large cell lymphoma|ALK-positive anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]" and "[[HAEM5:ALK-negative anaplastic large cell lymphoma|ALK-negative anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]"?
|-
|-
|T-cell and NK/T-cell Lymphomas||Disease||
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
|Disease
|
|
|
|
|
Line 821: Line 1,287:
|
|
|-
|-
|Erdheim-Chester Disease||Disease||
|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]]
|
|Disease
|
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|Rosai-Dorfman Disease||Disease||
|
|
====CHAPTER 11 (GERM CELL TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Juvenile Xanthogranuloma||Disease||
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]]
|Disease
|
|
|
|
|
|
|
|
|-
|Langerhans Cell Histiocytosis||Disease||
|
|
|
|
|
|
|
|
|-
|
|
====CHAPTER 12 (TUMOURS OF THE SELLAR REGION====
|
|
----
|
|
|-
----
|Histiocytic Sarcoma||Disease||
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|Germ Cell Tumours of the CNS||Disease||
|[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
|Disease
|
|
|
|
|
Line 875: Line 1,417:
|
|
|-
|-
|Adamantinomatous Craniopharyngioma||Disease||
|[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
|Disease
|
|
|
|
|
Line 884: Line 1,428:
|
|
|-
|-
|Papillary Craniopharyngioma||Disease||
|[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]]
|Disease
|
|
|
|
|
Line 893: Line 1,439:
|
|
|-
|-
|Pituicytoma, Granular Cell Tumour of the Sellar Region, and Spindle Cell Oncocytoma||Disease||
|[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
|Disease
|
|
|
|
|
Line 902: Line 1,450:
|
|
|-
|-
|Pituitary Adenoma/Pituitary Neuroendocrine Tumour||Disease||
|[[CNS5:Pituitary_blastoma|Pituitary blastoma]]
|Disease
|
|
|
|
|
Line 911: Line 1,461:
|
|
|-
|-
|Pituitary Blastoma||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|
|
====CHAPTER 13 (METASTASES TO THE CNS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Metastases to the Brain and Spinal Cord Parenchyma||Disease||
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]]
|Disease
|
|
|
|
|
|
|
|-
|Metastases to the Meninges||Disease||
|
|
|
|
Line 935: Line 1,503:
|
|
|
|
|-
|[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]]
|Disease
|
|
|
|
|-
|Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova
|
|
|
|
Line 945: Line 1,514:
|
|
|
|
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|-
|Neurofibromatosis Type 2||Disease||
|
|
====CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Schwannomatosis||Disease||
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Schwannomatosis|Schwannomatosis]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|Von Hippel-Lindau Syndrome||Disease||
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]]
|
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|Tuberous Sclerosis||Disease||
!'''Disease'''
|
!'''Page Type'''
|
!'''<span style="color:#0070C0">Author'''
|
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
|
!'''Author Content (Pending or Complete)'''
|
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Cowden_syndrome|Cowden syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|Li-Fraumeni Syndrome||Disease||
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
|
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|N/A
|N/A
|
|
|-
|-
|Cowden Syndrome||Disease||
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
|
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|N/A
|N/A
|
|
|-
|-
|Constitutional Mismatch Repair Deficiency Syndrome||Disease||Jennie Thurston
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]]
|7/2/2023
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|PENDING
|
|LS
|
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|-
|Familial Adenomatous Polyposis 1||Disease||Jennifer Laffin
|[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
|8/22/2023
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|PENDING
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|LS/MS
|
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|-
|Naevoid Basal Cell Carcinoma Syndrome||Disease||
|[[CNS5:Carney_complex|Carney complex]]
|
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|N/A
|N/A
|
|
|-
|-
|Rhabdoid Tumour Predisposition Syndrome||Disease||
|[[CNS5:DICER1_syndrome|DICER1 syndrome]]
|
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|N/A
|N/A
|
|
|-
|-
|Carney Complex||Disease||
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
|
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|N/A
|N/A
|
|
|-
|-
|DICER1 Syndrome||Disease||Jennie Thurston
|[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]]
|7/2/2023
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|PENDING
|
|LS
|
|NOT YET CREATED - See page "''DICER1''-Related Tumour Predisposition Syndrome (''DICER1'')" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|-
|Familial Paraganglioma Syndromes||Disease||
|[[CNS5:Familial_retinoblastoma|Familial retinoblastoma]]
|
|Disease
|
|
|
|
|
|
|
|-
|Melanoma-Astrocytoma Syndrome||Disease||
|
|
|
|
Line 1,073: Line 1,723:
|
|
|-
|-
|Familial Retinoblastoma||Disease||
!'''Disease'''
|
!'''Page Type'''
|
!'''<span style="color:#0070C0">Author'''
|
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
|
!'''Author Content (Pending or Complete)'''
|
!'''Date Completed by Author'''
|
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|BAP1 Tumour Predisposition Syndrome||Disease||
|[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
|
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|N/A
|N/A
|
|
|-
|-
|Fanconi Anaemia||Disease||
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]]
|
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|N/A
|N/A
|
|
|-
|-
|ELP1-Medulloblastoma Syndrome||Disease||
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]]
|
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|N/A
|N/A
|
|
|-
|-
|}<br />
|}
Retrieved from "https://content.ccga.io/index.php/CNS5:Volunteer_Assignments_and_Opportunities"